17 days ago
MCK
AnalystsMichael ChernyMichael Cherny's Stock Forecasts
AnalystsMichael Cherny
Analyst Ranking
Top 14%
#706 out of 5055 analysts
Average Return
+8.94%
Win Rate
57%55 out of 96
Risk vs Reward
Poor
Good
Michael Cherny's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Hims & Hers Health IncHIMS | +234.94% | $16.57 | $55.50 | 2024-09-12 - 2025-09-12 | Strong Buy |
Hims & Hers Health IncHIMS | +177.06% | $20.49 | $56.77 | 2024-06-02 - 2025-06-02 | Strong Buy |
Hims & Hers Health IncHIMS | +163.17% | $20.50 | $53.95 | 2024-10-13 - 2025-10-10 | Strong Buy |
Hims & Hers Health IncHIMS | +134.51% | $24.37 | $57.15 | 2024-06-12 - 2025-06-12 | Strong Buy |
Hims & Hers Health IncHIMS | +134.06% | $23.05 | $53.95 | 2024-10-20 - 2025-10-10 | Strong Buy |
Michael Cherny Analyst Color
Get additional color on Michael Cherny's coverage of popular stocks
2 months ago
CAH
4 months ago
CAH
5 months ago
MCK
8 months ago
HIMS
8 months ago
PGNY
a year ago
CVS
Michael Cherny's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mckesson CorpMCK | 11 | Buy | $850.00 | +11.32% | Maintains | 17 days ago |
Premier IncPINC | 8 | Sell | $21.00 | -24.41% | Maintains | 2 months ago |
Cardinal Health IncCAH | 8 | Buy | $186.00 | +18.56% | Maintains | 2 months ago |
Progyny IncPGNY | 8 | Buy | $28.00 | +39.30% | Upgrades | 3 months ago |
Boundless Bio IncBOLD | 2 | Hold | $3.00 | +136.22% | Downgrades | 4 months ago |
Envista Holdings CorpNVST | 7 | Strong Buy | $23.00 | +20.67% | Maintains | 5 months ago |
Medpace Holdings IncMEDP | 1 | Hold | $330.00 | -34.16% | Initiates Coverage On | 7 months ago |
Hims & Hers Health IncHIMS | 10 | Hold | $40.00 | -25.86% | Maintains | 8 months ago |
Cvs Health CorpCVS | 8 | Buy | $75.00 | -3.72% | Upgrades | 8 months ago |
Doximity IncDOCS | 2 | Buy | $90.00 | +37.17% | Upgrades | 8 months ago |
Align Technology IncALGN | 2 | Buy | $280.00 | +122.59% | Upgrades | 9 months ago |
Quest Diagnostics IncDGX | 2 | Buy | $174.00 | -5.47% | Upgrades | 9 months ago |
Henry Schein IncHSIC | 2 | Strong Buy | $84.00 | +32.97% | Upgrades | 9 months ago |
Patterson Companies IncPDCO | 11 | Hold | $31.35 | +0.06% | Downgrades | 10 months ago |
Iqvia Holdings IncIQV | 2 | Buy | $248.00 | +25.15% | Reiterates | a year ago |
Icon PLCICLR | 3 | Buy | $255.00 | +38.97% | Reiterates | a year ago |
Cencora IncCOR | 15 | Buy | $275.00 | N/A | Maintains | a year ago |
R1 Rcm IncRCM | 5 | Hold | $14.30 | N/A | Downgrades | a year ago |
Walgreens Boots Alliance IncWBA | 2 | Hold | $22.00 | N/A | Maintains | 2 years ago |
Labcorp Holdings IncLH | 1 | Buy | $260.00 | N/A | Initiates Coverage On | 2 years ago |
Goodrx Holdings IncGDRX | 4 | Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Certara IncCERT | 1 | Hold | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Dentsply Sirona IncXRAY | 3 | Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Accolade IncACCD | 6 | Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Teladoc Health IncTDOC | 1 | Hold | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Akili IncAKLI | 1 | Hold | $2.00 | N/A | Initiates Coverage On | 3 years ago |
Pear Therapeutics IncPEARQ | 1 | Hold | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Gohealth IncGOCO | 2 | Sell | $52.50 | N/A | Downgrades | 4 years ago |
Sonendo IncSONX | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Convey Health Solutions Holdings IncCNVY | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Signify Health IncSGFY | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Cerner CorpCERN | 1 | Sell | N/A | N/A | Downgrades | 5 years ago |
Cantel Medical CorpCMD | 1 | Sell | $51.00 | N/A | Initiates Coverage On | 5 years ago |
Veradigm IncMDRX | 2 | Strong Buy | $15.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.